The DOI matches its Crossref record; 133 of the 135 references it cites were found in a registry or an index.
Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes
Open accessAbstract
The incidence and prevalence of diabetes mellitus (DM) continue to grow dramatically throughout the world, due primarily to the increase in type 2 DM (T2DM). Although improvements in DM and hypertension management have reduced the proportion of diabetic individuals who develop chronic kidney disease (CKD) and progress to end-stage renal disease (ESRD), the sheer increase in people developing DM will have a major impact on dialysis and transplant needs. This KDIGO conference addressed a number of controversial areas in the management of DM patients with CKD, including aspects of screening for CKD with measurements of albuminuria and estimated glomerular filtration rate (eGFR); defining treatment outcomes; glycemic management in both those developing CKD and those with ESRD; hypertension goals and management, including blockers of the renin-angiotensin-aldosterone system; and lipid management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The absence of effect modification by baseline albuminuria contrasts with the findings from trials of RAS blockade.[31][32][33]”
From SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis (2019) · cites this paper as [33]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Diabetes management may be particularly challenging in individuals with chronic kidney disease who may be at an increased risk of hypoglycemia and in whom HbA 1c can be falsely low (276)”
From The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (2021) · cites this paper as [276]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · The Nephron journals/Nephron journals · doi:10.1159/000447068 · Cited by 11,782
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.10.018 · Cited by 8,530
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Standards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
Scottish Intercollegiate Guidelines Network
Twaddle, S., & Qureshi, S. (2005) · Evidence-based Healthcare and Public Health · doi:10.1016/j.ehbc.2005.09.008 · Cited by 4,080
Gupta, A., & Uribarri, J. (2016) · Hormone Research in Paediatrics · doi:10.1159/000444053 · Cited by 4,023
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.002 · Cited by 3,845
Telmisartan, ramipril, or both in patients at high risk for vascular events
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801317 · Cited by 3,502
(2012) · Kidney International Supplements · doi:10.1038/kisup.2012.73 · Cited by 3,247
Eplerenone in patients with systolic heart failure and mild symptoms
Zannad, F., McMurray, J. J. V., Krum, H., van Veldhuisen, D. J., Swedberg, K., Shi, H., Vincent, J., Pocock, S. J., & Pitt, B. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009492 · Cited by 3,111
Ohkubo, Y., Kishikawa, H., Araki, E., Miyata, T., Isami, S., Motoyoshi, S., Kojima, Y., Furuyoshi, N., & Shichiri, M. (1995) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(95)01064-k · Cited by 3,079
Basevi, V., Mario, S. D., Morciano, C., Nonino, F., & Magrini, N. (2011) · Diabetes Care · doi:10.2337/dc11-0174 · Cited by 3,058
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
Parving, H.-H., Lehnert, H., Bröchner-Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011489 · Cited by 2,873
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis
Wanner, C., Krane, V., März, W., Olschewski, M., Mann, J. F. E., Ruf, G., & Ritz, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043545 · Cited by 2,614
Self-citation[Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes].
Parving, H., Lehnert, H., Brøchner‐Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · PubMed · Cited by 2,527
(1958) · Journal of the American Pharmaceutical Association (Scientific ed ) · doi:10.1002/jps.3030470133 · Cited by 2,491
Baigent, C., Landray, M. J., Reith, C., Emberson, J., Wheeler, D. C., Tomson, C., Wanner, C., Krane, V., Cass, A., Craig, J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60739-3 · Cited by 2,479
Self-citationStandards of Medical Care in Diabetes—2012
(2012) · Diabetes Care · doi:10.2337/dc12-s011 · Cited by 2,240
Chronic Renal Failure after Transplantation of a Nonrenal Organ
OJO, A. O., Held, P. J., Port, F. K., Wolfe, R. A., Leichtman, A. B., Young, E. W., Arndorfer, J. A., Christensen, L. L., & Merion, R. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021744 · Cited by 2,216
(2000) · PubMed · Cited by 2,095
Collaborators, C. T. T. (. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60104-x · Cited by 2,081
Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
Fellström, B. C., Jardine, A. G., Schmieder, R. E., Holdaas, H., Bannister, K., Beutler, J., Chae, D.-W., Chevaile, A., Cobbe, S. M., Grönhagen-Riska, C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810177 · Cited by 2,036
Microalbuminuria Predicts Clinical Proteinuria and Early Mortality in Maturity-Onset Diabetes
Mogensen, C. E. (1984) · New England Journal of Medicine · doi:10.1056/nejm198402093100605 · Cited by 1,898
Self-citationPlasma aldosterone regulation in anephric man
Walker, W. G., & Cooke, C. R. (1973) · Kidney International · doi:10.1038/ki.1973.1 · Cited by 1,848
Adler, A., Stevens, R., Manley, S. E., Bilous, R., Cull, C. A., Holman, R. R., & UKPDS Group (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00712.x · Cited by 1,800
Self-citation(2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.12.005 · Cited by 1,788
Mann, J. F. E., Schmieder, R. E., McQueen, M., Dyal, L., Schumacher, H., Pogue, J. M., Wang, X., Maggioni, A. P., Budaj, A., Chaithiraphan, S., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61236-2 · Cited by 1,579
Lindholm, L. H., Ibsen, H., Dahlöf, B., Devereux, R. B., Beevers, G., de Faire, U., Fyhrquist, F., Julius, S., Kjeldsen, S. E., Kristiansson, K., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08090-x · Cited by 1,560
Cheung, A. K., Chang, T. I., Cushman, W. C., Furth, S. L., Hou, F. F., Ix, J. H., Knoll, G. A., Muntner, P., Pecoits-Filho, R., Sarnak, M. J., et al. (2021) · Kidney International · doi:10.1016/j.kint.2020.11.003 · Cited by 1,452
Ismail-Beigi, F., Craven, T., Banerji, M. A., Basile, J., Calles, J., Cohen, R. M., Cuddihy, R., Cushman, W. C., Genuth, S., Grimm, R. H., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60576-4 · Cited by 1,428
Fox, C. S., Matsushita, K., Woodward, M., Bilo, H. J., Chalmers, J., Heerspink, H. J. L., Lee, B. J., Perkins, R. M., Rossing, P., Sairenchi, T., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61350-6 · Cited by 1,401
Self-citationPreserving renal function in adults with hypertension and diabetes: A consensus approach
Bakris, G. L., Williams, M. E., Dworkin, L. D., Elliott, W. J., Epstein, M., Toto, R. D., Tuttle, K. R., Douglas, J. G., Hsueh, W. A., & Sowers, J. R. (2000) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2000.16225 · Cited by 1,396
KDOQI clinical practice guideline for diabetes and CKD: 2012 update
(2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.07.005 · Cited by 1,320
Cardiorenal end points in a trial of aliskiren for type 2 diabetes
Parving, H.-H., Brenner, B. M., McMurray, J. J. V., de Zeeuw, D., Haffner, S. M., Solomon, S. D., Chaturvedi, N., Persson, F., Desai, A. S., Nicolaides, M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1208799 · Cited by 1,319
Clinical pharmacokinetics of metformin
Graham, G. G., Punt, J., Arora, M., Day, R. O., Doogue, M. P., Duong, J. K., Furlong, T. J., Greenfield, J. R., Greenup, L. C., Kirkpatrick, C. M., et al. (2011) · Clinical Pharmacokinetics · doi:10.2165/11534750-000000000-00000 · Cited by 1,318
Intensive glucose control and macrovascular outcomes in type 2 diabetes
Turnbull, F. M., Abraira, C., Anderson, R. J., Byington, R. P., Chalmers, J. P., Duckworth, W. C., Evans, G. W., Gerstein, H. C., Holman, R. R., Moritz, T. E., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1470-0 · Cited by 1,189
Combined angiotensin inhibition for the treatment of diabetic nephropathy
Fried, L. F., Emanuele, N., Zhang, J. H., Brophy, M., Conner, T. A., Duckworth, W., Leehey, D. J., McCullough, P. A., O'Connor, T., Palevsky, P. M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1303154 · Cited by 1,169
Reversal of Lesions of Diabetic Nephropathy after Pancreas Transplantation
Fioretto, P., Steffes, M. W., Sutherland, D. E. R., Goetz, F. C., & Mauer, M. S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807093390202 · Cited by 1,125
van der Velde, M., Matsushita, K., Coresh, J., Astor, B. C., Woodward, M., Levey, A. S., de Jong, P. E., & Gansevoort, R. T. (2011) · Kidney International · doi:10.1038/ki.2010.536 · Cited by 1,082
Relation Between Kidney Function, Proteinuria, and Adverse Outcomes
Hemmelgarn, B. R. (2010) · JAMA · doi:10.1001/jama.2010.39 · Cited by 1,042
Smith, S. C., Jr. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/ahxt-ag78 · Cited by 1,037
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration
Altman, D. G., McShane, L. M., Sauerbrei, W., & Taube, S. E. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001216 · Cited by 1,034
Preventing Microalbuminuria in Type 2 Diabetes
Ruggenenti, P. L., Fassi, A., Parvanova, A. I., Bruno, S., Iliev, I. P., Brusegan, V., Rubis, N., Gherardi, G., Arnoldi, F., Ganeva, M. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042167 · Cited by 1,012
Clinical Practice Recommendations
Fowler, M. J. (2011) · Clinical Diabetes · doi:10.2337/diaclin.29.4.163 · Cited by 996
A Clinical Trial to Maintain Glycemic Control in Youth with Type 2 Diabetes
TODAY Study Group (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109333 · Cited by 993
Risk Factors for Renal Dysfunction in Type 2 Diabetes
Retnakaran, R., Cull, C. A., Thorne, K. I., Adler, A. I., Holman, R. R., & for the UKPDS Study Group (2006) · Diabetes · doi:10.2337/db05-1620 · Cited by 927
Self-citationHoldaas, H., Fellström, B., Jardine, A. G., Holme, I., Nyberg, G., Fauchald, P., Grönhagen-Riska, C., Madsen, S., Neumayer, H.-H., Cole, E., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13638-0 · Cited by 919
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
Salpeter, S. R., Greyber, E., Pasternak, G. A., & Salpeter (posthumous), E. E. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002967.pub4 · Cited by 893
Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes
Haller, H., Ito, S., Izzo, J. L., Januszewicz, A., Katayama, S., Menne, J., Mimran, A., Rabelink, T. J., Ritz, E., Ruilope, L. M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007994 · Cited by 792
Renal and retinal effects of enalapril and losartan in type 1 diabetes
Mauer, M., Zinman, B., Gardiner, R., Suissa, S., Sinaiko, A., Strand, T., Drummond, K., Donnelly, S., Goodyer, P., Gubler, M. C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808400 · Cited by 791
Astor, B. C., Matsushita, K., Gansevoort, R. T., van der Velde, M., Woodward, M., Levey, A. S., de Jong, P. E., & Coresh, J. (2011) · Kidney International · doi:10.1038/ki.2010.550 · Cited by 775
Casas, J. P., Chua, W., Loukogeorgakis, S., Vallance, P. J., Smeeth, L. L., Hingorani, A. D., & MacAllister, R. J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67814-2 · Cited by 738
Tonelli, M. A., Muntner, P., Lloyd, A. M., Manns, B., Klarenbach, S. W., Pannu, N., James, M. T., & Hemmelgarn, B. R. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60572-8 · Cited by 733
The Diabetes Control and Complications (DCCT) Research Group (1995) · Kidney International · doi:10.1038/ki.1995.236 · Cited by 694
(2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.193 · Cited by 653
Cooper-DeHoff, R. M., Gong, Y., Handberg, E. M., Bavry, A. A., Denardo, S. J., Bakris, G. L., & Pepine, C. J. (2010) · JAMA · doi:10.1001/jama.2010.884 · Cited by 651
Clinical Pharmacokinetics of Metformin
Scheen, A. J. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199630050-00003 · Cited by 649
Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes
The DCCT/EDIC Research Group (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1111732 · Cited by 568
(2012) · Kidney International Supplements · doi:10.1038/kisup.2012.46 · Cited by 522
Hayes, A. J., Leal, J., Gray, A. M., Holman, R. R., & Clarke, P. M. (2013) · Diabetologia · doi:10.1007/s00125-013-2940-y · Cited by 495
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
Salpeter, S. R., Greyber, E., Pasternak, G. A., & Salpeter, E. E. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002967.pub3 · Cited by 447
Use of Metformin in the Setting of Mild-to-Moderate Renal Insufficiency
Lipska, K. J., Bailey, C. J., & Inzucchi, S. E. (2011) · Diabetes Care · doi:10.2337/dc10-2361 · Cited by 432
Screening for Proteinuria in US Adults
Boulware, L. E., Jaar, B. G., Tarver-Carr, M. E., Brancati, F. L., & Powe, N. R. (2003) · JAMA · doi:10.1001/jama.290.23.3101 · Cited by 379
Pohl, M. A., Blumenthal, S. S., Cordonnier, D., de Álvaro, F., Deferrari, G., Eisner, G. M., Esmatjes, E., Gilbert, R. E., Hunsicker, L. G., de Faria, J. B. L., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004110919 · Cited by 372
Palmer, S. C., Craig, J. C., Navaneethan, S. D., Tonelli, M., Pellegrini, F., & Strippoli, G. F. M. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-4-201208210-00007 · Cited by 359
Thomas, M. C., Moran, J., Forsblom, C., Harjutsalo, V., Thorn, L., Ahola, A., Wadén, J., Tolonen, N., Saraheimo, M., Gordin, D., et al. (2011) · Diabetes Care · doi:10.2337/dc10-1722 · Cited by 349
Sleight, P., Redón, J., Verdecchia, P., Mancia, G., Gao, P., Fagard, R. H., Schumacher, H., Weber, M. A., Böhm, M., Williams, B., et al. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32832d7370 · Cited by 347
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
Palmer, S. C., Navaneethan, S. D., Craig, J. C., Johnson, D. W., Perkovic, V., Hegbrant, J., & Strippoli, G. F. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007784.pub2 · Cited by 336
Survival After Pancreas Transplantation in Patients With Diabetes and Preserved Kidney Function
Venstrom, J. M. (2003) · JAMA · doi:10.1001/jama.290.21.2817 · Cited by 328
Dietary salt intake and mortality in patients with type 2 diabetes
Ekinci, E. I., Clarke, S., Thomas, M. C., Moran, J. L., Cheong, K., MacIsaac, R. J., & Jerums, G. (2011) · Diabetes Care · doi:10.2337/dc10-1723 · Cited by 309
Molitch, M. E., Steffes, M., Sun, W., Rutledge, B., Cleary, P., de Boer, I. H., Zinman, B., Lachin, J., & for the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Group (2010) · Diabetes Care · doi:10.2337/dc09-1098 · Cited by 306
Self-citationSodium Intake, ACE Inhibition, and Progression to ESRD
Vegter, S., Perna, A., Postma, M. J., Navis, G. J., Remuzzi, G., & Ruggenenti, P. L. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011040430 · Cited by 305
Shepherd, J., Kastelein, J. J. P., Bittner, V., Deedwania, P., Breazna, A., Dobson, S., Wilson, D. J., Zuckerman, A., & Wenger, N. K. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.11.072 · Cited by 302
Shurraw, S. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.537 · Cited by 270
Heerspink, H. J. L., Holtkamp, F. A., Parving, H., Navis, G. J., Lewis, J. B., Ritz, E., de Graeff, P. A., & de Zeeuw, D. (2012) · Kidney International · doi:10.1038/ki.2012.74 · Cited by 259
Effect of Candesartan on Microalbuminuria and Albumin Excretion Rate in Diabetes
Bilous, R., Chaturvedi, N., Sjølie, A. K., Fuller, J., Klein, R., Orchard, T., Porta, M., & Parving, H.-H. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-1-200907070-00120 · Cited by 257
Colhoun, H. M., Betteridge, D. J., Durrington, P. N., Hitman, G. A., Neil, H. A. W., Livingstone, S. J., Charlton-Menys, V., DeMicco, D. A., & Fuller, J. H. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.03.022 · Cited by 255
Renoprotection of Optimal Antiproteinuric Doses (ROAD) Study
Hou, F. F., Xie, D., Zhang, X., Chen, P. Y., Zhang, W. R., Liang, M., Guo, Z. J., & Jiang, J. P. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006121372 · Cited by 254
Makino, H., Haneda, M., Babazono, T., Moriya, T., Ito, S., Iwamoto, Y., Kawamori, R., Takeuchi, M., Katayama, S., & for the INNOVATION Study Group (2007) · Diabetes Care · doi:10.2337/dc06-1998 · Cited by 230
Breyer, J. A., Bain, R. P., Evans, J. K., Nahman, N. S., Lewis, E. J., Cooper, M., McGill, J. B., Berl, T., & the Collaborative Study Group (1996) · Kidney International · doi:10.1038/ki.1996.481 · Cited by 225
So, W. Y., Kong, A. P. S., Ronald, C. W., Ozaki, R., Szeto, C., Chan, N. N., Ng, V. S. W., Ho, C. S., Lam, C. W. K., Chow, C. C., et al. (2006) · Diabetes Care · doi:10.2337/dc06-0248 · Cited by 208
Self-citationTaler, S. J., Agarwal, R., Bakris, G. L., Flynn, J. T., Nilsson, P. M., Rahman, M., Sanders, P. W., Textor, S. C., Weir, M. R., & Townsend, R. R. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.03.018 · Cited by 201
Tonelli, M. A., Jose, P. O., Curhan, G. C., Sacks, F. M., D, E. B. M., & Pfeffer, M. A. (2006) · BMJ · doi:10.1136/bmj.38814.566019.2f · Cited by 193
Glycemic Control and Cardiovascular Mortality in Hemodialysis Patients With Diabetes
Ricks, J., Molnar, M. Z., Kovesdy, C. P., Shah, A. P., Nissenson, A. R., Williams, M. E., & Kalantar‐Zadeh, K. (2012) · Diabetes · doi:10.2337/db11-1015 · Cited by 193
Systematic review on urine albumin testing for early detection of diabetic complications
Newman, D., Mattock, M., Dawnay, A., Kerry, S., McGuire, A., Yaqoob, M., Hitman, G., & Hawke, C. (2005) · Health Technology Assessment · doi:10.3310/hta9300 · Cited by 192
Diabetic kidney disease with and without albuminuria
MacIsaac, R. J., & Jerums, G. (2011) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3283456546 · Cited by 190
Lipid-Lowering Therapy in Persons With Chronic Kidney Disease
Upadhyay, A., Earley, A., Lamont, J. L., Haynes, S. M., Wanner, C., & Balk, E. M. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-4-201208210-00005 · Cited by 166
Self-citationNew-Onset Diabetes After Kidney Transplantation—Changes and Challenges
Yates, C. J., Fourlanos, S., Hjelmesaeth, J. S., Colman, P. G., & Cohney, S. J. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03855.x · Cited by 148
Glycemic Control and Survival in Peritoneal Dialysis Patients with Diabetes Mellitus
Duong, U., Mehrotra, R., Molnar, M. Z., Noori, N., Kovesdy, C. P., Nissenson, A. R., & Kalantar‐Zadeh, K. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08921010 · Cited by 145
Rachmani, R., Slavachevski, I., Levi, Z., Zadok, B.-S., Kedar, Y., & Ravid, M. (2002) · European Journal of Internal Medicine · doi:10.1016/s0953-6205(02)00131-0 · Cited by 134
(2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.007 · Cited by 129
Fried, L. F., Duckworth, W. C., Zhang, J. H., O’Connor, T., Brophy, M. T., Emanuele, N., Huang, G. D., McCullough, P. A., Palevsky, P. M., Seliger, S. L., et al. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03350708 · Cited by 128
Cystatin C, Albuminuria, and Mortality Among Older Adults With Diabetes
de Boer, I. H., Katz, R., Cao, J. J., Fried, L. F., Kestenbaum, B. R., Mukamal, K. J., Rifkin, D. E., Sarnak, M. J., Shlipak, M. G., & Siscovick, D. S. (2009) · Diabetes Care · doi:10.2337/dc09-0191 · Cited by 127
Over 500 Solitary Pancreas Transplants in Nonuremic Patients with Brittle Diabetes Mellitus
Gruessner, R. W. G., Sutherland, D. E. R., Kandaswamy, R., & Gruessner, A. C. (2008) · Transplantation · doi:10.1097/01.tp.0000296820.46978.3f · Cited by 118
Rosuvastatin in Diabetic Hemodialysis Patients
Holdaas, H., Holme, I., Schmieder, R. E., Jardine, A. G., Zannad, F. M., Norby, G. E., & Fellström, B. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010090987 · Cited by 118
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
Navaneethan, S. D., Pansini, F., Perkovic, V., Manno, C., Pellegrini, F., Johnson, D. W., Craig, J. C., & Strippoli, G. F. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007784 · Cited by 117
American Diabetes Association: clinical practice recommendations 1997.
(1997) · PubMed · Cited by 116
Oakley, W. (1950) · BMJ · doi:10.1136/bmj.1.4648.287-a · Cited by 114
Hemoglobin A1c Levels and Mortality in the Diabetic Hemodialysis Population
Ramirez, S. P. B., McCullough, K. P., Thumma, J. R., Nelson, R. G., Morgenstern, H., Gillespie, B. W., Inaba, M., Jacobson, S. H., Vanholder, R. C., Pisoni, R. L., et al. (2012) · Diabetes Care · doi:10.2337/dc12-0573 · Cited by 105
Self-citationOlmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes
Haller, H. G., Ito, S., Izzo, J. L., Januszewicz, A., Katayama, S., Menne, J., Mimran, A., Rabelink, T. J., Ritz, E., Ruilope, L. M., et al. (2012) · Survey of Anesthesiology · doi:10.1097/01.sa.0000412361.12996.3b · Cited by 104
Chronic Kidney Disease in Diabetes
McFarlane, P. A., Gilbert, R. E., MacCallum, L., & Senior, P. A. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.037 · Cited by 102
Impact of metabolic control in progression of clinical diabetic nephropathy
Nyberg, G., Blohmé, G., & Nordén, G. (1987) · Diabetologia · doi:10.1007/bf00274576 · Cited by 100
Japan nephrology society (2012) · PubMed · Cited by 98
Blood Pressure Control in Chronic Kidney Disease
Lewis, J. B. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010030236 · Cited by 94
Metformin: The Safest Hypoglycaemic Agent in Chronic Kidney Disease?
Nye, H. J., & Herrington, W. G. (2011) · Nephron Clinical Practice · doi:10.1159/000323739 · Cited by 92
Clinical Practice Guidebook for Diagnosis and Treatment of Chronic Kidney Disease
Matsuo, S., Watanabe, T., Iino, Y., Uchida, S., Iseki, K., Imai, E., Kimura, K., Tsukamoto, Y., Nitta, K., Hara, S., et al. (2009) · Clinical and Experimental Nephrology · Cited by 90
(2010) · The Lancet · doi:10.1016/s0140-6736(10)61995-2 · Cited by 81
Review: Metformin: Potential benefits and use in chronic kidney disease
Pilmore, H. (2010) · Nephrology · doi:10.1111/j.1440-1797.2010.01328.x · Cited by 69
Mulec, H., Blohmé, G., Grande, B. M., & Björck, S. (1998) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/13.3.651 · Cited by 65
Management of Dyslipidemias in Patients with Diabetes and Chronic Kidney Disease
Molitch, M. E. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00780306 · Cited by 62
Self-citationScalea, J. R., Butler, C., Munivenkatappa, R. B., Nogueira, J. M., Campos, L., Haririan, A., Barth, R. N., Philosophe, B., Bartlett, S. T., & COOPER, M. M. (2008) · Transplantation · doi:10.1097/tp.0b013e3181913fbf · Cited by 57
Tacrolimus and Cyclosporine Nephrotoxicity in Native Kidneys of Pancreas Transplant Recipients
Fioretto, P., Najafian, B., Sutherland, D. E. R., & Mauer, M. S. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03850510 · Cited by 51
Molnar, M. Z., Huang, E., Hoshino, J., Krishnan, M., Nissenson, A. R., Kovesdy, C. P., & Kalantar‐Zadeh, K. (2011) · Diabetes Care · doi:10.2337/dc11-0906 · Cited by 34
Shastri, S., Katz, R., Shlipak, M. G., Kestenbaum, B. R., Peralta, C. A., Kramer, H., Jacobs, D. R., de Boer, I. H., Cushman, M., Siscovick, D. S., et al. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.11.021 · Cited by 29
Is Cystatin C the Answer to Detecting Progression in CKD?
de Jong, P. E., & Gansevoort, R. T. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010111189 · Cited by 2
Flagged first, then by citations
2 of the 135 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Kidney Disease: Improving Global Outcomes (KDIGO) Lipid Work Group, 2013, KDIGO Clinical Practice Guideline for Lipid Management in Chronic Kidney Disease, Kindey Int Suppl, 3, 259
Cited by
Sorted by citations
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Wanner, C., Inzucchi, S. E., Lachin, J. M., Fitchett, D., von Eynatten, M., Mattheus, M., Johansen, O. E., Woerle, H. J., Broedl, U. C., & Zinman, B. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1515920 · Cited by 3,655
Self-citationLiraglutide and renal outcomes in type 2 diabetes
Mann, J. F. E., Ørsted, D. D., Brown-Frandsen, K., Marso, S. P., Poulter, N. R., Rasmussen, S., Tornøe, K., Zinman, B., & Buse, J. B. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1616011 · Cited by 1,253
Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014
Afkarian, M., Zelnick, L. R., Hall, Y. N., Heagerty, P. J., Tuttle, K., Weiss, N. S., & de Boer, I. H. (2016) · JAMA · doi:10.1001/jama.2016.10924 · Cited by 1,026
Neuen, B. L., Young, T., Heerspink, H. J. L., Neal, B., Perkovic, V., Billot, L., Mahaffey, K. W., Charytan, D. M., Wheeler, D. C., Arnott, C., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30256-6 · Cited by 893
Self-citationHolt, R. I. G., DeVries, J. H., Hess-Fischl, A., Hirsch, I. B., Kirkman, M. S., Klupa, T., Ludwig, B., Nørgaard, K., Pettus, J., Renard, E., et al. (2021) · Diabetes Care · doi:10.2337/dci21-0043 · Cited by 699
Metadata
- Authors
- Molitch, M. E., Adler, A. I., Flyvbjerg, A., Nelson, R. G., So, W.-Y., Wanner, C., Kasiske, B. L., Wheeler, D. C., de Zeeuw, D., & Mogensen, C. E.
- Affiliations
- Northwestern University (US)
- Addenbrooke's Hospital (GB)
- Aarhus University (DK)
- National Institute of Diabetes and Digestive and Kidney Diseases (US)
- Chinese University of Hong Kong (HK)
- Universitätsklinikum Würzburg (DE)
- Hennepin County Medical Center (US)
- University College London (GB)
- Aarhus University Hospital (DK)
- Corresponding author
- Molitch, Mark E.
- ORCID
- Venue
- Kidney International
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 87
- Issue
- 1
- Pages
- 20-30
- ISSN
- 0085-2538 (ISSN-L)
- PMC
- PMC4214898
- OpenAlex
- W2136160292
- Semantic Scholar
- f2af4f6271bd70cd0bbaacb694a7a365a61dea86
- Cited by
- 268
- References
- 135
- Citations by year
- 2026: 18 · 2025: 17 · 2024: 20 · 2023: 17 · 2022: 24 · 2021: 31 · 2020: 34 · 2019: 22 · 2018: 26 · 2017: 23 · 2016: 15 · 2015: 15
- FWCI
- 15.29
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Kidney International (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
- PubMed Central (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- diabetic nephropathy, chronic kidney disease, type 2 diabetes, end-stage renal disease, albuminuria, estimated glomerular filtration rate, CKD screening, glycemic control, antihypertensive therapy, renin-angiotensin-aldosterone system inhibitors, lipid control, treatment outcomes
- MeSH terms
- Albuminuria, Diabetic Nephropathies, Humans, Hyperglycemia, Hypertension, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
